MARGO GILLMAN: Open Payments
NPI 1932479136 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 95 payments from 24 companies in 2025. Trend: 2023 $47 · 2024 $685 · 2025 $1,773
Food & beverage: $1,773
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $265 |
| ABBVIE INC. | 11 | $176 |
| ViiV Healthcare Company | 8 | $176 |
| Lilly USA, LLC | 10 | $171 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $99 |
| PFIZER INC. | 5 | $97 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Abbott Laboratories | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
Products named: MOUNJARO, VRAYLAR, DOVATO, Wegovy, REXULTI, Kerendia, TRELEGY ELLIPTA, Rybelsus.
Industry payments across MI — which companies pay providers there.
